Tizanidine
Product Images NDC 70934-811

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70934-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 811 30 Master Bottle Label Approval Rev A 01 21)

This is a medicine with NDC number 70934-811-30. It is in the form of tablets containing 4mg Tizanidine as an active ingredient. The package contains 30 tablets. The remaining text is not readable and contains a few non-English characters.*

FDA Label Image

Fig1 (Fig1)

This is a table showing the plasma tizanidine concentration in ng/mL for different dosages and timings. The table includes data for 4mg tizanidine tablets and capsules, taken with or without food at different hours from dosing. No additional information is available.*

FDA Label Image

Fig2 (Fig2)

The text appears to be a graph or a table without any further details. It is not possible to generate a useful description with this information.*

FDA Label Image

Fig3 (Fig3)

The text describes an improvement in Ashworth score using a medication called Zanidine at a mean dose of 28.6 mg. It is unclear what condition or disease is being treated. The improvement is evaluated at Study Week 3 and the end of maintenance endpoint is at Study Week 7 using last observation carried forward.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.